Rogue immune cells linked to leukemia found to be a key driver of autoimmune diseases

by Garvan Institute of Medical ResearchA killer T cell (centre) hunting a target cell. Credit: NIH Image GalleryGene variants associated with leukemia can produce "rogue" immune cells t

Updated on: February 20,2024

Rogue immune cells linked to leukemia found to be a key driver of autoimmune diseases

by Garvan Institute of Medical ResearchA killer T cell (centre) hunting a target cell. Credit: NIH Image GalleryGene variants associated with leukemia can produce "rogue" immune cells t

Updated on:February 20,2024

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Updated on: February 20,2024

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Updated on:February 20,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on: January 12,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on:January 12,2024

Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Patients with detectable PSA (0.2-2.0 ng/mL) post-prostatectomy considered for salvage radiotherapy undergoing18F-DCFPyL P

Updated on: January 22,2024

Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Patients with detectable PSA (0.2-2.0 ng/mL) post-prostatectomy considered for salvage radiotherapy undergoing18F-DCFPyL P

Updated on:January 22,2024

How post-feeding breasts bounce back from the brink of death to kick-start milk production

byUniversity of SheffieldDelayed alveolar regression in Rac1−/− glands in involution. (A-D) Carmine staining of whole-mounted mammary glands of WT (A, C) and Rac1−/− (B, D) mice at postlactation

Updated on: January 02,2024

How post-feeding breasts bounce back from the brink of death to kick-start milk production

byUniversity of SheffieldDelayed alveolar regression in Rac1−/− glands in involution. (A-D) Carmine staining of whole-mounted mammary glands of WT (A, C) and Rac1−/− (B, D) mice at postlactation

Updated on:January 02,2024

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)

Updated on: February 24,2024

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)

Updated on:February 24,2024

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on: May 11,2024

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on:May 11,2024

With 'batwing' mastopexy, more women can undergo nipple-sparing mastectomy

by Wolters Kluwer HealthCredit: Unsplash/CC0 Public DomainNipple-sparing techniques can provide better outcomes for women undergoing breast reconstruction after mastectomy—but due to complication

Updated on: February 18,2024

With 'batwing' mastopexy, more women can undergo nipple-sparing mastectomy

by Wolters Kluwer HealthCredit: Unsplash/CC0 Public DomainNipple-sparing techniques can provide better outcomes for women undergoing breast reconstruction after mastectomy—but due to complication

Updated on:February 18,2024

New tool pinpoints gaps in awareness of blood cancer symptoms

byUniversity of SurreySymptom awareness. *Cough was included as a non-blood cancer symptom. Credit:BMC Cancer(2023). DOI: 10.1186/s12885-023-11149-xA new tool could help identify gap

Updated on: January 13,2024

New tool pinpoints gaps in awareness of blood cancer symptoms

byUniversity of SurreySymptom awareness. *Cough was included as a non-blood cancer symptom. Credit:BMC Cancer(2023). DOI: 10.1186/s12885-023-11149-xA new tool could help identify gap

Updated on:January 13,2024

Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer

by Bill Lubinger,Case Western Reserve UniversityA hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single stran

Updated on: April 29,2024

Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer

by Bill Lubinger,Case Western Reserve UniversityA hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single stran

Updated on:April 29,2024

Cancer survivors predicted to number over 22 million by 2030

by American Cancer SocietyCredit: CC0 Public DomainThere were more than 16.9 million Americans with a history of cancer on January 1, 2019, a number that is projected to reach more than 22.1 mill

Updated on: March 06,2024

Cancer survivors predicted to number over 22 million by 2030

by American Cancer SocietyCredit: CC0 Public DomainThere were more than 16.9 million Americans with a history of cancer on January 1, 2019, a number that is projected to reach more than 22.1 mill

Updated on:March 06,2024

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on: March 20,2024

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on:March 20,2024